Age (years) |
62.8±0.7 |
Men, n (%) |
88 (66.7) |
AF type-Paroxysmal, n (%) |
72 (54.5) |
AF duration (months) |
75.1±6.5 |
Comorbidities |
|
Hypertension, n (%) |
81 (61.4) |
Diabetes mellitus, n (%) |
11 (8.3) |
Coronary artery disease, n (%) |
1 (8.3) |
Cardiovascular ICD, n (%)
|
4 (3.0)
|
CHA2DS2-VASc score |
1.7±0.1 |
Drug therapy |
|
ACEI/ARB, n (%) |
62 (47.0) |
β-blockers, n (%) |
47 (35.6) |
CCB, n (%) |
29 (22.0) |
Diuretics, n (%) |
13 (9.8) |
OAC-Warfarin, n (%) |
59 (44.7) |
OAC-NOACs, n (%) |
33 (25.0) |
eGFR baseline |
78.0±0.7 |
Echocardiographic parameters |
|
LVEF (%) |
64.8±0.4 |
LAD (mm) |
39.0±0.5 |
LVDd (mm) |
47.2±0.5 |